Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season.

Bella A, Gesualdo F, Orsi A, Arcuri C, Chironna M, Loconsole D, Napoli C, Orsi GB, Manini I, Montomoli E, Alfonsi V, Castrucci MR, Rizzo C.

Expert Rev Vaccines. 2019 Jun;18(6):671-679. doi: 10.1080/14760584.2019.1627206. Epub 2019 Jun 13.

PMID:
31159616
2.

Serologic and Virologic Evidence of Influenza A Viruses in Wild Boars ( Sus scrofa) from Two Different Locations in Italy.

Delogu M, Cotti C, Vaccari G, Raffini E, Frasnelli M, Nicoloso S, Biacchessi V, Boni A, Foni E, Castrucci MR, De Marco MA.

J Wildl Dis. 2019 Jan;55(1):158-163. doi: 10.7589/2017-11-285. Epub 2018 Sep 20.

PMID:
30235085
3.

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.

Gallinaro A, Borghi M, Bona R, Grasso F, Calzoletti L, Palladino L, Cecchetti S, Vescio MF, Macchia D, Morante V, Canitano A, Temperton N, Castrucci MR, Salvatore M, Michelini Z, Cara A, Negri D.

Front Immunol. 2018 Feb 5;9:171. doi: 10.3389/fimmu.2018.00171. eCollection 2018.

4.

Correction to: Detection and full genome characterization of two beta CoV viruses related to Middle East respiratory syndrome from bats in Italy.

Moreno A, Lelli D, De Sabato L, Zaccaria G, Boni A, Sozzi E, Prosperi A, Lavazza A, Cella E, Castrucci MR, Ciccozzi M, Vaccari G.

Virol J. 2018 Jan 12;15(1):10. doi: 10.1186/s12985-018-0921-y.

5.

Detection and full genome characterization of two beta CoV viruses related to Middle East respiratory syndrome from bats in Italy.

Moreno A, Lelli D, de Sabato L, Zaccaria G, Boni A, Sozzi E, Prosperi A, Lavazza A, Cella E, Castrucci MR, Ciccozzi M, Vaccari G.

Virol J. 2017 Dec 19;14(1):239. doi: 10.1186/s12985-017-0907-1. Erratum in: Virol J. 2018 Jan 12;15(1):10.

6.

Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination.

Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci MR, De Vito R, Tucci FM, McDermott AB, Narpala S, Rossi P, Koup RA, Palma P, Petrovas C.

J Immunol. 2018 Jan 15;200(2):538-550. doi: 10.4049/jimmunol.1701312. Epub 2017 Dec 13.

7.

Strategies to obtain multiple recombinant modified vaccinia Ankara vectors. Applications to influenza vaccines.

Barbieri A, Panigada M, Soprana E, Di Mario G, Gubinelli F, Bernasconi V, Recagni M, Donatelli I, Castrucci MR, Siccardi AG.

J Virol Methods. 2018 Jan;251:7-14. doi: 10.1016/j.jviromet.2017.10.003. Epub 2017 Oct 4.

PMID:
28987424
8.

Factors affecting immune responses to the influenza vaccine.

Castrucci MR.

Hum Vaccin Immunother. 2018 Mar 4;14(3):637-646. doi: 10.1080/21645515.2017.1338547. Epub 2017 Jul 21. Review.

9.

Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.

Di Mario G, Soprana E, Gubinelli F, Panigada M, Facchini M, Fabiani C, Garulli B, Basileo M, Cassone A, Siccardi A, Donatelli I, Castrucci MR.

Pathog Glob Health. 2017 Mar;111(2):69-75. doi: 10.1080/20477724.2016.1275464. Epub 2017 Jan 12.

10.

Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.

Di Mario G, Sciaraffia E, Facchini M, Gubinelli F, Soprana E, Panigada M, Bernasconi V, Garulli B, Siccardi A, Donatelli I, Castrucci MR.

Pathog Glob Health. 2017 Mar;111(2):76-82. doi: 10.1080/20477724.2016.1275465. Epub 2017 Jan 12.

11.

Highly pathogenic avian influenza A(H5N8) outbreaks: protection and management of exposed people in Europe, 2014/15 and 2016.

Adlhoch C, Brown IH, Angelova SG, Bálint Á, Bouwstra R, Buda S, Castrucci MR, Dabrera G, Dán Á, Grund C, Harder T, van der Hoek W, Krisztalovics K, Parry-Ford F, Popescu R, Wallensten A, Zdravkova A, Zohari S, Tsolova S, Penttinen P.

Euro Surveill. 2016 Dec 8;21(49). pii: 30419. doi: 10.2807/1560-7917.ES.2016.21.49.30419.

12.

Human-Animal Interface: The Case for Influenza Interspecies Transmission.

Donatelli I, Castrucci MR, De Marco MA, Delogu M, Webster RG.

Adv Exp Med Biol. 2017;972:17-33. doi: 10.1007/5584_2016_136.

PMID:
27677275
13.

Influenza A(H7N7) Virus among Poultry Workers, Italy, 2013.

Puzelli S, Rizzo C, Fabiani C, Facchini M, Gaibani P, Landini MP, Gagliotti C, Moro ML, Rangoni R, Piccolomini LL, Finarelli AC, Tamba M, Rezza G, Declich S, Donatelli I, Castrucci MR.

Emerg Infect Dis. 2016 Aug;22(8):1512-3. doi: 10.3201/eid2208.160246. No abstract available.

14.

Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.

Rizzo C, Bella A, Alfonsi V, Puzelli S, Palmieri AP, Chironna M, Pariani E, Piatti A, Tiberti D, Ghisetti V, Rangoni R, Colucci ME, Affanni P, Germinario C, Castrucci MR.

Vaccine. 2016 Jun 8;34(27):3102-3108. doi: 10.1016/j.vaccine.2016.04.072. Epub 2016 May 4.

PMID:
27154392
15.

A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.

Di Mario G, Garulli B, Sciaraffia E, Facchini M, Donatelli I, Castrucci MR.

Virol J. 2016 Mar 31;13:56. doi: 10.1186/s12985-016-0513-7.

16.

Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings.

Valentini D, Marcellini V, Bianchi S, Villani A, Facchini M, Donatelli I, Castrucci MR, Marasco E, Farroni C, Carsetti R.

Vaccine. 2015 Nov 27;33(48):6689-96. doi: 10.1016/j.vaccine.2015.10.083. Epub 2015 Oct 28.

17.

Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013.

Puzelli S, Rossini G, Facchini M, Vaccari G, Di Trani L, Di Martino A, Gaibani P, Vocale C, Cattoli G, Bennett M, McCauley JW, Rezza G, Moro ML, Rangoni R, Finarelli AC, Landini MP, Castrucci MR, Donatelli I; Influenza Task Force.

Emerg Infect Dis. 2014 Oct;20(10):1745-9. doi: 10.3201/eid2010.140512.

18.

Induction of antibodies and T cell responses by a recombinant influenza virus carrying an HIV-1 TatΔ51-59 protein in mice.

Garulli B, Di Mario G, Stillitano MG, Compagnoni D, Titti F, Cafaro A, Ensoli B, Kawaoka Y, Castrucci MR.

Biomed Res Int. 2014;2014:904038. doi: 10.1155/2014/904038. Epub 2014 May 14.

19.

B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012-2013 flu vaccination experience.

Rinaldi S, Cagigi A, Santilli V, Zotta F, di Martino A, Castrucci MR, Donatelli I, Poggi E, Piazza A, Campana A, Guzzo I, Villani A, Rossi P, Dello Strologo L, Palma P.

Transplantation. 2014 Aug 15;98(3):259-66. doi: 10.1097/TP.0000000000000209.

PMID:
24911036
20.

Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza.

Garulli B, Di Mario G, Stillitano MG, Kawaoka Y, Castrucci MR.

Vaccine. 2014 May 1;32(21):2501-6. doi: 10.1016/j.vaccine.2014.02.077. Epub 2014 Mar 21.

PMID:
24662706
21.

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).

Pedrazzoli P, Baldanti F, Donatelli I, Castrucci MR, Puglisi F, Silvestris N, Cinieri S; Italian Society of Medical Oncology.

Ann Oncol. 2014 Jun;25(6):1243-7. doi: 10.1093/annonc/mdu114. Epub 2014 Mar 11.

PMID:
24618150
22.

Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.

Castrucci MR, Facchini M, Di Mario G, Garulli B, Sciaraffia E, Meola M, Fabiani C, De Marco MA, Cordioli P, Siccardi A, Kawaoka Y, Donatelli I.

Influenza Other Respir Viruses. 2014 May;8(3):367-75. doi: 10.1111/irv.12221. Epub 2013 Dec 23.

23.

Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.

Rinaldi S, Zangari P, Cotugno N, Manno EC, Brolatti N, Castrucci MR, Donatelli I, Rossi P, Palma P, Cagigi A.

Vaccine. 2014 Feb 3;32(6):657-63. doi: 10.1016/j.vaccine.2013.12.008. Epub 2013 Dec 13.

PMID:
24333344
24.

Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013.

Puzelli S, Azzi A, Santini MG, Di Martino A, Facchini M, Castrucci MR, Meola M, Arvia R, Corcioli F, Pierucci F, Baretti S, Bartoloni A, Bartolozzi D, de Martino M, Galli L, Pompa MG, Rezza G, Balocchini E, Donatelli I.

Euro Surveill. 2013 Aug 22;18(34). pii: 20564.

25.

Evidence of cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy.

De Marco MA, Porru S, Cordioli P, Cesana BM, Moreno A, Calzoletti L, Bonfanti L, Boni A, Di Carlo AS, Arici C, Carta A, Castrucci MR, Donatelli I, Tomao P, Peri VM, Di Trani L, Vonesch N.

PLoS One. 2013;8(2):e57576. doi: 10.1371/journal.pone.0057576. Epub 2013 Feb 28.

26.

Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo.

Garulli B, Di Mario G, Sciaraffia E, Accapezzato D, Barnaba V, Castrucci MR.

Vaccine. 2013 Mar 25;31(13):1717-24. doi: 10.1016/j.vaccine.2013.01.037. Epub 2013 Feb 1.

PMID:
23380456
27.

Immunogenicity of a recombinant influenza virus bearing both the CD4+ and CD8+ T cell epitopes of ovalbumin.

Garulli B, Di Mario G, Sciaraffia E, Kawaoka Y, Castrucci MR.

J Biomed Biotechnol. 2011;2011:497364. doi: 10.1155/2011/497364. Epub 2011 Oct 5.

28.

Protective immunity to influenza: lessons from the virus for successful vaccine design.

Garulli B, Castrucci MR.

Expert Rev Vaccines. 2009 Jun;8(6):689-93. doi: 10.1586/erv.09.35. Review.

PMID:
19485749
29.

Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo.

Garulli B, Stillitano MG, Barnaba V, Castrucci MR.

Clin Vaccine Immunol. 2008 Oct;15(10):1497-504. doi: 10.1128/CVI.00166-08. Epub 2008 Aug 27.

30.

Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.

Garulli B, Meola M, Stillitano MG, Kawaoka Y, Castrucci MR.

Virology. 2007 May 10;361(2):274-82. Epub 2007 Jan 11.

31.

Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection.

Chapman TJ, Castrucci MR, Padrick RC, Bradley LM, Topham DJ.

Virology. 2005 Sep 30;340(2):296-306.

33.

The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.

Mueller SN, Jones CM, Chen W, Kawaoka Y, Castrucci MR, Heath WR, Carbone FR.

J Virol. 2003 Feb;77(4):2445-51.

34.

The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia.

Topham DJ, Castrucci MR, Wingo FS, Belz GT, Doherty PC.

J Immunol. 2001 Dec 15;167(12):6983-90.

35.

Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.

Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y.

J Virol. 2000 Sep;74(18):8502-12.

36.

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y.

J Virol. 2000 Jul;74(13):6015-20.

37.
38.

A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.

Stevenson PG, Belz GT, Castrucci MR, Altman JD, Doherty PC.

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9281-6.

39.

Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase.

Kobasa D, Kodihalli S, Luo M, Castrucci MR, Donatelli I, Suzuki Y, Suzuki T, Kawaoka Y.

J Virol. 1999 Aug;73(8):6743-51.

40.

Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses.

Kawaoka Y, Gorman OT, Ito T, Wells K, Donis RO, Castrucci MR, Donatelli I, Webster RG.

Virus Res. 1998 Jun;55(2):143-56.

PMID:
9725667
41.

The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction.

Vines A, Wells K, Matrosovich M, Castrucci MR, Ito T, Kawaoka Y.

J Virol. 1998 Sep;72(9):7626-31.

42.

Molecular basis for the generation in pigs of influenza A viruses with pandemic potential.

Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y.

J Virol. 1998 Sep;72(9):7367-73.

43.

The M2 ectodomain is important for its incorporation into influenza A virions.

Park EK, Castrucci MR, Portner A, Kawaoka Y.

J Virol. 1998 Mar;72(3):2449-55.

44.

The cysteine residues of the M2 protein are not required for influenza A virus replication.

Castrucci MR, Hughes M, Calzoletti L, Donatelli I, Wells K, Takada A, Kawaoka Y.

Virology. 1997 Nov 10;238(1):128-34.

45.

Nuclear import and export of influenza virus nucleoprotein.

Neumann G, Castrucci MR, Kawaoka Y.

J Virol. 1997 Dec;71(12):9690-700.

46.

HEL-Flu: an influenza virus containing the hen egg lysozyme epitope recognized by CD4+ T cells from mice transgenic for an alphabeta TCR.

Walker WS, Castrucci MR, Sangster MY, Carson RT, Kawaoka Y.

J Immunol. 1997 Sep 15;159(6):2563-6.

PMID:
9300673
47.

Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy.

Campitelli L, Donatelli I, Foni E, Castrucci MR, Fabiani C, Kawaoka Y, Krauss S, Webster RG.

Virology. 1997 Jun 9;232(2):310-8.

48.

Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users.

Iorio AM, Alatri A, Francisci D, Preziosi R, Neri M, Donatelli I, Castrucci MR, Biasio LR, Tascini C, Iapoce R, Pierucci P, Baldelli F.

Vaccine. 1997 Jan;15(1):97-102.

PMID:
9041673

Supplemental Content

Loading ...
Support Center